ECSP077160A - Nuevos d-homo-estra-1,3,5(10)-trienos sustituidos en la posición 2 como inhibidores de 17 -hidroxiesteroide deshidrogenasa tipo 1 - Google Patents

Nuevos d-homo-estra-1,3,5(10)-trienos sustituidos en la posición 2 como inhibidores de 17 -hidroxiesteroide deshidrogenasa tipo 1

Info

Publication number
ECSP077160A
ECSP077160A EC2007007160A ECSP077160A ECSP077160A EC SP077160 A ECSP077160 A EC SP077160A EC 2007007160 A EC2007007160 A EC 2007007160A EC SP077160 A ECSP077160 A EC SP077160A EC SP077160 A ECSP077160 A EC SP077160A
Authority
EC
Ecuador
Prior art keywords
sub
sup
estra
homo
dehydrogenase type
Prior art date
Application number
EC2007007160A
Other languages
English (en)
Inventor
Alexander Hillisch
Olaf Peters
Walter Elger
Birgitt Schneider
Christian Gege
Wilko Regenhardt
Jerzy Adamski
Gabriele Moeller
Dominga Deluca
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ECSP077160A publication Critical patent/ECSP077160A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Nuevos D-homo-estra-1,3,5(10)-trienos sustituidos en la posición 2 de fórmula general (I), donde R2 significa un grupo alquilo C1-C8, un grupo alquiloxi C1-C8 o un átomo de halógeno, R3 significa un átomo de hidrógeno o un grupo metilo, R17 significa un átomo de hidrógeno o un átomo de flúor, así como sus sales aceptables para uso farmacéutico, su producción y uso como agentes farmacéuticos para la profilaxis y terapia de enfermedades dependientes de estrógeno sobre las que puede influir la inhibición de la 17 -hidroxiesteroide deshidrogenasa tipo 1.
EC2007007160A 2004-07-02 2007-01-10 Nuevos d-homo-estra-1,3,5(10)-trienos sustituidos en la posición 2 como inhibidores de 17 -hidroxiesteroide deshidrogenasa tipo 1 ECSP077160A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004032673A DE102004032673A1 (de) 2004-07-02 2004-07-02 Neue 2-substituierte D-Homo-estra-1,3,5(10)-triene als Inhibitoren der 17ß-Hydroxysteroiddehydrogenase Typ 1

Publications (1)

Publication Number Publication Date
ECSP077160A true ECSP077160A (es) 2007-02-28

Family

ID=35106828

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007160A ECSP077160A (es) 2004-07-02 2007-01-10 Nuevos d-homo-estra-1,3,5(10)-trienos sustituidos en la posición 2 como inhibidores de 17 -hidroxiesteroide deshidrogenasa tipo 1

Country Status (25)

Country Link
EP (1) EP1763534B1 (es)
JP (1) JP4871274B2 (es)
KR (1) KR20070035059A (es)
CN (1) CN1980949B (es)
AT (1) ATE458744T1 (es)
AU (1) AU2005259329B8 (es)
BR (1) BRPI0511394A (es)
CA (1) CA2571760C (es)
CR (1) CR8854A (es)
DE (2) DE102004032673A1 (es)
DK (1) DK1763534T3 (es)
EA (1) EA011455B1 (es)
EC (1) ECSP077160A (es)
ES (1) ES2340401T3 (es)
HK (1) HK1103745A1 (es)
HR (1) HRP20100230T1 (es)
IL (1) IL180171A0 (es)
MX (1) MX2007000108A (es)
NO (1) NO20070605L (es)
NZ (1) NZ552515A (es)
PL (1) PL1763534T3 (es)
PT (1) PT1763534E (es)
UA (1) UA92324C2 (es)
WO (1) WO2006003012A1 (es)
ZA (1) ZA200700958B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
US8080540B2 (en) 2006-09-19 2011-12-20 Abbott Products Gmbh Therapeutically active triazoles and their use
US8288367B2 (en) 2006-11-30 2012-10-16 Solvay Pharmaceuticals Gmbh Substituted estratriene derivatives as 17BETA HSD inhibitors
DE102007015169A1 (de) 2007-03-27 2008-10-02 Universität des Saarlandes Campus Saarbrücken 17Beta-Hydroxysteroid-Dehydrogenase-Typ1-Inhibitoren zur Behandlung hormonabhängiger Erkrankungen
DE102007040243A1 (de) 2007-08-25 2009-02-26 Universität des Saarlandes 17Beta-Hydroxysteriod-Dehydrogenase Typ1 Inhibitoren zur Behandlung hormonabhängiger Erkrankungen
US9850272B2 (en) 2013-06-25 2017-12-26 Forendo Pharma Ltd. Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1
US10377791B2 (en) 2013-06-25 2019-08-13 Forendo Pharma Ltd. Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1
US9663549B2 (en) 2013-06-25 2017-05-30 Forendo Pharma Ltd. Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase
CN107207562B (zh) 2014-12-23 2020-03-06 佛恩多制药有限公司 17β-HSD1抑制剂的前药
CN107207561B (zh) 2014-12-23 2020-03-31 佛恩多制药有限公司 17β-HSD1–抑制剂的前药
CZ307437B6 (cs) 2016-06-07 2018-08-22 Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. 15β-substituované deriváty estronu jako selektivní inhibitory 17β-hydroxysteoiddehydrogenáz
UA126342C2 (uk) 2017-06-08 2022-09-21 Форендо Фарма Лтд 15-бета-[3-пропанамідо]-заміщені естра-1,3,5(10)-трієн-17-он-сполуки і їх 17-оксими для використання в інгібуванні 17-бета-гідроксистероїддегідрогеназ
SG11202105795XA (en) 2018-12-05 2021-06-29 Forendo Pharma Ltd Estra-1,3,5(10)-triene compounds condensed in position 16(17) with a pyrazole ring as inhibitors of 17-hsd1

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005835A (en) * 1960-09-13 1961-10-24 Searle & Co D-homo-18-norestra-1, 3, 5(10)-trien-17alpha-ones and intermediates thereto
GB1346691A (en) * 1970-06-12 1974-02-13 Inst Khim Prirodnykh Soedineny Stereospecific method for preparing estrane compounds of natural configuration
JPH06279488A (ja) * 1993-03-29 1994-10-04 Kuraray Co Ltd 新規なステロイド誘導体および骨粗鬆症治療剤
PL343862A1 (en) * 1998-03-11 2001-09-10 Endorech Inhibitors of type 5 and type 3 17β−hydroxysteroid dehydrogenase and methods for their use
DE10151365A1 (de) * 2001-10-17 2003-04-30 Schering Ag 17-Chlor-D-Homosteroide als selektive Estrogenrezeptorantagonisten
WO2003017974A1 (en) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Method of treating benign gynaecological disorders and a pharmaceutical kit for use in such method
DE10307103A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
DE102004032674A1 (de) * 2004-07-02 2006-01-26 Schering Ag Neue 2-substituierte Estra-1,3,5(10)-trien-17-one als Inhibitoren der 17β-Hydroxysteroiddehydrogenase Typ 1

Also Published As

Publication number Publication date
ES2340401T3 (es) 2010-06-02
CA2571760A1 (en) 2006-01-12
AU2005259329B8 (en) 2011-11-24
AU2005259329A1 (en) 2006-01-12
MX2007000108A (es) 2007-03-09
DK1763534T3 (da) 2010-05-17
CN1980949B (zh) 2010-05-05
PT1763534E (pt) 2010-04-27
EP1763534B1 (de) 2010-02-24
ZA200700958B (en) 2008-07-30
CN1980949A (zh) 2007-06-13
EP1763534A1 (de) 2007-03-21
WO2006003012A1 (de) 2006-01-12
KR20070035059A (ko) 2007-03-29
PL1763534T3 (pl) 2010-07-30
CR8854A (es) 2007-08-28
HRP20100230T1 (hr) 2010-06-30
UA92324C2 (en) 2010-10-25
ATE458744T1 (de) 2010-03-15
DE102004032673A1 (de) 2006-01-26
JP2008504337A (ja) 2008-02-14
JP4871274B2 (ja) 2012-02-08
IL180171A0 (en) 2007-06-03
EA200700103A1 (ru) 2007-08-31
CA2571760C (en) 2011-11-22
EA011455B1 (ru) 2009-04-28
NO20070605L (no) 2007-02-01
NZ552515A (en) 2010-07-30
HK1103745A1 (en) 2007-12-28
DE502005009091D1 (de) 2010-04-08
BRPI0511394A (pt) 2007-12-04
AU2005259329B2 (en) 2011-11-10

Similar Documents

Publication Publication Date Title
ECSP077160A (es) Nuevos d-homo-estra-1,3,5(10)-trienos sustituidos en la posición 2 como inhibidores de 17 -hidroxiesteroide deshidrogenasa tipo 1
RS54260B1 (en) AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT
CO5570670A2 (es) Pulmonar obstructiva cronica
TW200833675A (en) Nicotinamide derivatives
DE60315674D1 (de) Neue imidazopyridine und ihre verwendung
MY153393A (en) Amino nicotinic and isonicotinic acid derivatives as dhodh as inhibitors
NO20084129L (no) Pyridin(3,4-B)Pyrazinoner
TW200616620A (en) Compounds for the treatment of inflammatory disorders
TN2010000293A1 (en) Thiazole derivatives used as pi 3 kinase inhibitors
NO20074057L (no) 2,4-Diaminopyridopyrimidinderivater og deres anvendelse som mTOR-inhibitorer
ATE537175T1 (de) Neue piperazino-dihydrothienopyrimidin-derivate
TW200612911A (en) Compounds for the treatment of inflammatory disorders
ATE388146T1 (de) 1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
NO20090166L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
WO2009075835A8 (en) CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
MX2010001020A (es) Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas.
NZ605827A (en) Co-crystals and salts of ccr3-inhibitors
MX2009010731A (es) Derivados de acido 1-(1-bencilpiperidin-4-il)benzimidazol-5-carbox ilico para el tratamiento de diabetes mellitus.
WO2006003013A3 (de) NEUE 2-SUBSTITUIERTE ESTRA-1,3,5(10)-TRIEN-17-ONE ALS INHIBITOREN DER 17β-HYDROXYSTEROIDDEHYDROGENASE TYP 1
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
MX2009010727A (es) Heterociclos como antagonistas de orexina.
ATE495159T1 (de) Diaminocyclohexan- und diaminocyclopentanderivate
WO2005053702A3 (en) Anti-inflammatory agents
EA201070814A1 (ru) Производные 6-гетероциклоимидазо[1,2-а]пиридин-2-карбоксамидов, их получение и их применение в терапии
JP2007507467A5 (es)